Combination therapies of amlodipine with other agents causing blockade of the renin–angiotensin–aldosterone pathway (angiotensin II receptor blockers or renin inhibitors) have shown successful blood pressure reduction approaches to decrease the risk of CV and progression of renal disease. Here, REN is linked to kidney disorder.